Successful reintroduction of methotrexate after acute pneumonitis in a patient with acute lymphoblastic leukemia

Low-dose methotrexate (MTX) is used as disease-modifying therapy in severe rheumatoid arthritis and as maintenance treatment in patients with complete remission of acute lymphoblastic leukemia (ALL). It is generally well tolerated, but in 27% of patients acute pneumonitis leads to discontinuation of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2003-03, Vol.82 (3), p.193-196
Hauptverfasser:	FEHR, T, JACKY, E, BÄCHLI, E. B
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Biological and medical sciences Female Hematologic and hematopoietic diseases Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Mercaptopurine - administration & dosage Methotrexate - administration & dosage Methotrexate - adverse effects Middle Aged Pneumonia - chemically induced Pneumonia - diagnosis Pneumonia - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Prednisone - therapeutic use Remission Induction Tomography, X-Ray Computed
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!